NewsMV
In focus for $CODX: Co-Diagnostics, Inc. failed to achieve a quorum at its Annual Meeting of Stockholders on September 3, 2026, leaving all scheduled business untransacted.
The company adjourned the meeting to September 24, 2026, at 9:00 a.m. Mountain Time, when stockholders will reconvene at the company's Salt Lake City, Utah offices at 2401 S.
A quorum failure does not register on the tape the way a guidance cut or a deal close does.
It does carry a read on where the float actually is relative to the vote, and the 8-K, filed September 4 and signed by CEO Dwight Egan as principal executive officer, offers no explanation for why the meeting fell short.
Keep reading